Antineoplastic Agents
Preventing Med Errors Program
A program to present practical ways to prevent medication errors with antineoplastic agents, identify common types of medication errors, and describe a system for reducing and responding appropriately to antineoplastic medication errors. View Preventing Med Errors Program - Part 1
View Preventing Med Errors Program - Part 2
ASHP Guidelines
The purpose of these guidelines is to assist practitioners in improving their antineoplastic medication-use system and error-prevention programs. They supplement ASHP's Guidelines on Preventing Medication Errors in Hospitals and address error prevention within diverse health care settings. Further, these guidelines provide updated general guidance to include a standard definition of a “medication error” and applicable aspects of recommendations from the National Coordinating Council on Medication Error Reporting and Prevention (NCCMERP).
View ASHP Antineoplastic Guidelines
|
|
Insulin
Safe Use of Insulin
Accurate administration of insulin has gone from complex to downright confusing. There
are now more than 20 insulin products available, and the administration rules have
changed. Rules many nurses learned regarding visualization tests, mixing, and
intravenous administration of all clear solutions no longer apply. In addition to all these
changes, many organizations eliminated double-checks of subcutaneous or intravenous
insulin before dministration—only to realize that they now need to reinstitute
independent cognitive double-checks as one component of an effective patient safety
program.
View Article: Safe Use of Insulin
UHC February 2005 |
